Cleave Biosciences, Inc. is a company founded in 2011.
Edgewise Therapeutics is a drug discovery and biotechnology company developing products based on the understanding of skeletal muscle.
Silverback Therapeutics is a Seattle-based biopharmaceutical company developing ImmunoTAC therapies targeting previously inaccessible disease pathways.